Kutsal, YGEskiyurt, NIrdesel, JSepici, VUgurlu, HKirazli, YArdic, FKorsic, MVlak, TGrlickov, MTemelkova, SMLazarov, MPilipovic, NPopovic, VDimic, AKovacev, BRuci, DTafaj, AKucukalic-Selimovic, EAvdic, DSeleskovic, HPejicic, SButun, BAkyuz, GCerrahoglu, LSendur, OFYalcin, POncel, SSaridogan, MSarpel, TTosun, MSenel, KGursoy, SCantürk, FDemir, HMiskic, BKrpan, DSkreb, FGrazio, SCrncevic-Orlic, ZOzdener, FOncel, H2025-04-102025-04-108756-3282http://hdl.handle.net/20.500.14701/43172EnglishA candidate-identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronateMeeting Abstract